Polymorphism and its Implications in Pharmaceutical Product Development

Amit Bhatia,Shruti Chopra,Kalpana Nagpal,Pran Kishore Deb,Muktika Tekade,Rakesh K. Tekade
DOI: https://doi.org/10.1016/b978-0-12-814421-3.00002-6
2018-01-01
Abstract:Most of the pharmaceutical products are solids; therefore, the knowledge of solid-state characteristics of any active pharmaceutical ingredients (APIs) and excipients is vital for their development as a successful drug product. Knowledge of the physical and chemical properties such as solubility and stability of materials during the initial stages of drug development helps to prevent the difficulties in their manufacturing and moreover improve their quality. Hence, the understanding of polymorphism and crystal behavior of any pharmaceutically relevant materials is highly required. Polymorphism is the property of solid materials to exist in two or more crystalline forms with different conformations or orientations of the components in the crystal lattice. The polymorphs of a material may vary in their physicochemical characteristics, such as dissolution, solubility, stability, and hygroscopicity, etc. Polymorphs may also differ in other important drug aspects like efficacy, bioavailability, and toxicity. Thus, a particular property of a polymorph might not be exhibited by another polymorph of same material. This chapter will deal with all the aspects of polymorphism which include the theories, preparation, characterization, and their pharmaceutical importance.
What problem does this paper attempt to address?